Ignite Creation Date:
2024-05-06 @ 3:36 AM
Last Modification Date:
2024-10-26 @ 11:36 AM
Study NCT ID:
NCT02332512
Status:
UNKNOWN
Last Update Posted:
2017-02-24
First Post:
2015-01-04
Brief Title:
Study of Apatinib as 3rd4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor EGFR
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Organization Data
Organization:
Jiangsu HengRui Medicine Co Ltd
Class:
INDUSTRY
Study ID:
HR-APTN-Ⅲ-NSCLC-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jiangsu HengRui Medicine Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None